Lifecome Biochemistry002868.SZValuation Analysis

As of Oct 19, 2026, Lifecome Biochemistry (002868.SZ) trades at a negative P/E (-42.61x, due to a recent net loss), P/B of 44.10x, P/S of 6.31x, and a dividend yield of 0.00%.
Longitudinal percentile comparison: P/E historical percentile is still accumulating data over the trailing long-term window (vs. the short-term percentile still accumulating data); P/B sits at the 89th percentile over the trailing 10Y window (vs. 56th percentile over 3Y); P/S sits at the 38th percentile over the trailing 10Y window (vs. 47th percentile over 3Y).
Cross-sectional valuation: its P/B ranks at the 98th percentile within its industry and the 99th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 0.00%; its historical percentile over the trailing long-term window is still accumulating data.
Its P/B percentile is roughly the same whether measured against the industry or the broader market. Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. Lifecome Biochemistry operates in the Agriculture, Forestry, Animal Husbandry and Fishery sector. Data refreshes weekly and is for reference only, not investment advice.